EP3244912

TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS WITH LIXISENATIDE

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    15.1.2016
  • EP published:
    18.8.2021
  • EP application number:
    16700758.2
  • Max expiry date:
    14.1.2036
  • Title:
    TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS WITH LIXISENATIDE

Timeline

Today
15.1.2016EP application
18.8.2021EP Publication

Owner

  • Name:
    Sanofi-Aventis Deutschland GmbH
  • Address:
    Brüningstraße 50, 65929 Frankfurt, DE

Inventor

  • Name:
    BERGMANN, Karin
  • Address:
    65926 Frankfurt am Main, DE
  • Name:
    HINCELIN-MÉRY, Agnès
  • Address:
    75008 Paris, FR
  • Name:
    JAN, Christelle
  • Address:
    75008 Paris, FR

Priority

  • Number:
    15151488
  • Date:
    16.1.2015
  • Country:
    EP

Classification

  • Categories:
    A61K 38/26, A61P 3/10

Upload documents